Is there a generic for Hydroflumethiazide; reserpine?

Yes. The FDA Orange Book lists 5 approved generic (ANDA) applications for Hydroflumethiazide; reserpine, referencing the brand SALUTENSIN. Generics rated with an "A" therapeutic-equivalence code are considered substitutable for the brand.

What is the reference-listed drug for Hydroflumethiazide; reserpine?

SALUTENSIN (NDA 012359, SHIRE) is the reference-listed drug — the approved product a generic applicant must show its version is the same as.

What dosage forms of Hydroflumethiazide; reserpine are approved?

Hydroflumethiazide; reserpine is approved in the following dosage form: tablet.

FDA Orange Book · active-ingredient family

Hydroflumethiazide; reserpine

Hydroflumethiazide; reserpine is approved as 1 brand and 5 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:SALUTENSIN · NDA 012359

Brand (NDA)

Generics (ANDA)

Listed patents

Exclusivity periods

Brand (NDA) products · tablet

Product	Applicant	Application	TE	Approved
SALUTENSIN×2	SHIRE	NDA 012359	—	Approved Prior to Jan 1, 1982

Generic (ANDA) products (5)

Product	Applicant	Application	TE	Approved
RESERPINE AND HYDROFLUMETHIAZIDE	PAR PHARM	ANDA 088907	—	Sep 20, 1985
RESERPINE AND HYDROFLUMETHIAZIDE	IVAX PHARMS	ANDA 088932	—	Jan 11, 1985
HYDROFLUMETHIAZIDE AND RESERPINE	USL PHARMA	ANDA 088195	—	Oct 26, 1983
HYDROFLUMETHIAZIDE AND RESERPINE	WATSON LABS	ANDA 088127	—	Mar 22, 1983
HYDROFLUMETHIAZIDE AND RESERPINE	WATSON LABS	ANDA 088110	—	Mar 22, 1983

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Hydroflumethiazide; reserpine — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo